Bendroflumethiazide
Brand names,
Bendroflumethiazide
Analogs
Bendroflumethiazide
Brand Names Mixture
- Corzide Tab W Nadolol 40mg (Bendroflumethiazide + Nadolol)
- Corzide Tab W Nadolol 80mg (Bendroflumethiazide + Nadolol)
Bendroflumethiazide
Chemical_Formula
C15H14F3N3O4S2
Bendroflumethiazide
RX_link
No information avaliable
Bendroflumethiazide
fda sheet
Bendroflumethiazide
msds (material safety sheet)
Bendroflumethiazide
Synthesis Reference
No information avaliable
Bendroflumethiazide
Molecular Weight
421.417 g/mol
Bendroflumethiazide
Melting Point
221-223 oC
Bendroflumethiazide
H2O Solubility
108 mg/L
Bendroflumethiazide
State
Solid
Bendroflumethiazide
LogP
2.085
Bendroflumethiazide
Dosage Forms
Tablet
Bendroflumethiazide
Indication
For the treatment of high blood pressure and management of edema
Bendroflumethiazide
Pharmacology
Bendroflumethiazide, a thiazide diuretic, removes excess water from the body by increasing how often you urinate (pass water) and also widens the blood vessels which helps to reduce blood pressure. It inhibits Na+/Cl- reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue.
Bendroflumethiazide
Absorption
Absorbed relatively rapidly after oral administration
Bendroflumethiazide
side effects and Toxicity
No information avaliable
Bendroflumethiazide
Patient Information
No information avaliable
Bendroflumethiazide
Organisms Affected
Humans and other mammals